Who invested in Rodeo Therapeutics?
Rodeo Therapeutics's investors include Eli Lilly, AbbVie, ARCH Venture Partners, Alexandria Venture Investments and Alexandria Real Estate Equities, and 5 more on record.
United States · Venture startup
Funding summaryUpdated 26 Oct 2026
$15Mraised across 2 rounds since 2017, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $3.7M sold, first sale Nov 2018
Reported by FinSMEsSEC filing: $5.4M sold, first sale Jul 2017
From the SEC filings it signed: 4 on the team.
On the board, as filediAsish XavierKatie HewittMargarita ChavezSanford MarkowitzSteve GillisTadataka Yamada
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Rodeo Therapeutics's investors include Eli Lilly, AbbVie, ARCH Venture Partners, Alexandria Venture Investments and Alexandria Real Estate Equities, and 5 more on record.
Rodeo Therapeutics has raised $15M across 2 rounds since 2017.
Rodeo Therapeutics's most recent round was a Venture of $8.9M in Nov 2018.
Its most recent round, $8.9M in Nov 2018, is also its largest on record.
Rodeo Therapeutics's first round on record, in Jul 2017, was backed by Eli Lilly, Alexandria Real Estate Equities and AbbVie and 5 others.
Rodeo Therapeutics's latest named round is a Venture, in Nov 2018.
Rodeo Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.